• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Addition of claims-based frailty index enhances current Medicare cost prediction model

byThomas SuandDeepti Shroff
April 16, 2020
in Chronic Disease, Public Health
Reading Time: 3 mins read
Share on FacebookShare on Twitter

1. In this retrospective study, augmentation of the Centers for Medicare & Medicaid Services Hierarchical Condition Category cost prediction model with a validated claims-based frailty index significantly improved its accuracy at different levels of frailty.

2. While its estimates were more precise on average, the improved model was still not able to account for dramatic variation within each frailty category.

Evidence Rating Level: 2 (Good)

Study Rundown: In order to ensure that healthcare consumers are charged fairly for their costs of care, Medicare has adopted the Centers for Medicare & Medicaid Services Hierarchical Condition Category (CMS-HCC) risk-adjustment cost prediction model in a move toward value-based payment. While this model accounts for a substantial range of comorbidities, conditions such as frailty or reduced functional status can escape notice, shifting unexpected costs to providers. A recently-developed claims-based frailty index (CFI) has already been tested as a predictor of clinical outcomes, but its utility in forecasting costs is unknown. This study evaluated whether the addition of the CFI to the CMS-HCC enhanced model accuracy, finding that the CMS-HCC+CFI was able to provide a more comprehensive view of the factors affecting patients compared to the CMS-HCC alone. Some annualized Medicare costs (AMCs) that were unexplained under the standard model were projected by the CFI, and the hybrid model also better characterized patients with dual enrollment in Medicaid. These improvements come at no additional cost to clinicians as the index can be calculated directly from existing Medicare data, although in-person examinations may be more beneficial for correctly classifying patients. Of note, this model does not apply well to individual patients due to wide variation in cost within frailty categories.

Click here to read the study in Annals of Internal Medicine

Click here to read an accompanying editorial in Annals of Internal Medicine

RELATED REPORTS

Physical frailty is associated with increased risk of epilepsy

2 Minute Medicine Rewind May 18, 2026

Housing insecurity is associated with increased risk of geriatric conditions and mortality

In-Depth [retrospective cohort]: In this study, information about 16535 Medicare Current Beneficiary Survey (MCBS) participants was linked to their fee-for-service claims and administrative data from 2006 to 2013. Individuals were eligible for inclusion if they had at least 1 year of continuous enrollment in Medicare parts A and B to serve as a baseline and either remained enrolled for at least 1 additional year or died in the following year. Those receiving long-term care were excluded because frailty adjustment would not have revealed additional information beyond their institutionalization. Patients were stratified as robust, prefrail, mildly frail, or moderately to severely frail based on diagnoses (e.g. anemia or infection) and use of medical services or equipment (e.g. supplemental oxygen or wheelchairs). Further, 88% of patients were either robust or prefrail, and only 2.5% were moderately to severely frail. Multivariable regression was used to predict annualized Medicare costs (AMCs) for both the CMS-HCC and the CMS-HCC+CFI models, and data and calculated residuals were depicted in the form of kernel density plots. The CMS-HCC model overpredicted costs for robust patients while underpredicting costs for mildly and moderately to severely frail patients. Addition of the CFI, while not perfect, successfully reduced the magnitude of misprediction in all but the 4th cost quintile. For those who were dually enrolled in both Medicare and Medicaid, while the standard model underpredicted costs by an average of $632, the composite model had nearly perfect accuracy, underestimating costs by only $1.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cmsfrailtygeriatricsvalue-based payment
Previous Post

Results from remdesivir compassionate use study for severe COVID-19

Next Post

Decreased risk of ovarian cancer in women who have breastfed

RelatedReports

Home nursing visits for elderly after hospitalization may reduce short term mortality
Chronic Disease

Physical frailty is associated with increased risk of epilepsy

May 20, 2026
Transthoracic echocardiography can rule out endocarditis in low-risk bacteremic patients
Weekly Rewinds

2 Minute Medicine Rewind May 18, 2026

May 18, 2026
Chronic Disease

Housing insecurity is associated with increased risk of geriatric conditions and mortality

May 7, 2026
Systematic review examines benefits and adverse effects of cannabinoid therapy
Weekly Rewinds

2 Minute Medicine Rewind May 4, 2026

May 4, 2026
Next Post
The SOLO1 trial: Olaparib significantly delays progression of advanced ovarian cancer

Decreased risk of ovarian cancer in women who have breastfed

#VisualAbstract: A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

#VisualAbstract: A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant

SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.